Preparation method of natural polymer antibacterial fiber as well as product and application of natural polymer antibacterial fiber

By coating chitosan on cellulose fibers, natural polymer antibacterial fibers with skin core structures are prepared, and the strength and cost of existing natural antibacterial fiber materials are solved, and natural polymer antibacterial with high strength and high-efficiency antibacterial effects are achieved fiber.

CN119020875APending Publication Date: 2024-11-26INST OF CHEM CHINESE ACAD OF SCI
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202310593062.7
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2023-05-24
Publication Date
2024-11-26

AI Technical Summary

Technical Problem

The existing natural antibacterial fiber materials are difficult to achieve long-lasting antibacterial activity and high strength while maintaining the wearability of fabrics. The conversion and extraction of chitosan fibers are difficult and expensive, which limits their application.

Method used

Natural polymer antibacterial fibers with a skin core structure are prepared by solidification bath method, using cellulose as the core layer material and chitosan as the cortical coating material, combined with chemical crosslinking or physical coating method, the strength and antibacterial fibers are improved and antibacterial fibers are improved by combining with chemical crosslinking or physical coating method. Rate.

Benefits of technology

High-strength natural polymer antibacterial fibers are realized, which solves the problem of low strength of chitosan fibers, and realizes continuous preparation of antibacterial fibers, reduces production costs, and has good economic benefits and environmental significance.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN119020875A_ABST
    Figure CN119020875A_ABST
Patent Text Reader

Abstract

The invention relates to a preparation method of a natural polymer antibacterial fiber, the natural polymer antibacterial fiber prepared by the method and application of the natural polymer antibacterial fiber. The method comprises the following steps: extruding a natural polymer solution through a spinning tank nozzle, sequentially carrying out first coagulating bath and antibacterial component coagulating bath, and drying to obtain the natural polymer antibacterial fiber, or the commercial natural polymer fiber is directly subjected to an antibacterial component coagulating bath and is dried to prepare the natural polymer antibacterial fiber. The natural polymer antibacterial fiber is prepared from the natural polymer fiber and the antibacterial component, an excellent ionic liquid biomass solvent system is adopted in the method, water, alcohol and the functional component (namely the antibacterial component) serve as a coagulating bath, and the prepared antibacterial fiber is good in uniformity and stability and controllable in antibacterial rate.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present invention belongs to the field of natural polymer materials, and in particular, relates to a preparation method of a natural polymer antibacterial fiber and a product and application thereof. Background Art

[0002] In recent years, the rampant development of bacteria and viruses has brought catastrophic problems to human life. Therefore, it is urgent to develop durable antibacterial and antiviral materials to protect human health and safety. Medical protective products are the first line of defense against bacteria and viruses that infringe on human health, so it is necessary to give protective fabrics antibacterial and antiviral properties. In the past few decades, a large number of antimicrobial agents have been developed for the cotton textile industry. They are roughly divided into two categories: inorganic agents and organic agents. Inorganic antimicrobial agents mainly refer to metal nanoparticles, including silver, copper, zinc and copper oxide, which show unique and advantageous antibacterial activity. However, most inorganic antimicrobial agents cannot achieve durable antibacterial activity due to their poor affinity for cotton fibers. Organic synthetic antimicrobial agents, such as quaternary ammonium salts, guanidine derivatives and organic halides, generally exhibit lower antibacterial activity than inorganic antimicrobial agents, and their poor heat resistance usually makes them susceptible to high temperatures during textile processing. Many natural antimicrobial agents, such as borneol, polyphenols and betaine, are also frequently used to prepare antibacterial cotton fabrics. However, applying special processes to impart wash durability while maintaining the fabric’s wearing comfort and reliable safety remains a major challenge.

[0003] Chitosan is the second largest biomass in the world after cellulose. It is a deacetylated derivative of chitin. Due to its high chemical reactivity, good antibacterial activity, good biocompatibility and good biodegradability, it is widely used in many fields such as food additives, textiles, agriculture, antibacterial agents, medical fibers and other daily chemical industries. However, compared with cellulose, the conversion and extraction of chitosan is more difficult and therefore expensive. At the same time, due to the poor mechanical properties of chitosan fiber and the limited solvents used in the preparation process, the development and application of chitosan fiber has been greatly hindered. Summary of the invention

[0004] Based on the deficiencies of the prior art, the present invention provides a method for preparing a natural high molecular weight antibacterial fiber, a natural high molecular weight antibacterial fiber prepared by the method, and an application thereof. The present invention prepares a fiber with a skin-core structure by a coagulation bath method to solve the above problems. Specifically, the core layer material is cellulose, which provides mechanical properties, and chitosan is coated on the surface of the cellulose fiber as a skin layer through the diffusion function of the coagulation bath to prepare the natural high molecular weight antibacterial fiber.

[0005] The present invention provides the following technical solutions:

[0006] A method for preparing a natural polymer antibacterial fiber, the method comprising the following steps: extruding a natural polymer solution through a spinning tank nozzle, and sequentially passing through a first coagulation bath and an antibacterial component coagulation bath, and drying to obtain the natural polymer antibacterial fiber; or directly passing commercial natural polymer fibers through an antibacterial component coagulation bath, and drying to obtain the natural polymer antibacterial fiber.

[0007] According to an embodiment of the present invention, the natural polymer solution is obtained by dissolving a natural polymer material in a solvent.

[0008] According to an embodiment of the present invention, in the natural polymer solution, the concentration (solid content) of the natural polymer material is 3wt%-15wt%; specifically 6wt%-9wt%; illustratively, it can be 3wt%, 4wt%, 5wt%, 6wt%, 7wt%, 8wt%, 9wt%, 10wt%, 11wt%, 12wt%, 13wt%, 14wt% or 15wt%.

[0009] According to an embodiment of the present invention, the natural polymer material is cellulose; or low-quality cellulose or natural plant tissue.

[0010] According to an embodiment of the present invention, the first coagulation bath is water, alcohol or a mixed solution of water and alcohol.

[0011] According to an embodiment of the present invention, the alcohol is selected from methanol, ethanol, propanol, n-butanol, glycerol, ethylene glycol, isopropanol or isobutanol.

[0012] According to an embodiment of the present invention, the antibacterial component coagulation bath is a solution of chitosan or its derivatives, specifically, the solution is an aqueous solution; the concentration (solid content) of the solution is, for example, 1wt%-20wt%, or 3wt%-10wt%, specifically 2wt%, 3wt%, 4wt%, 5wt%, 6wt%, 7wt%, 8wt%, 9wt%, 10wt%, 11wt%, 12wt%, 13wt%, 14wt% or 15wt%; preferably 3wt% to 6wt%.

[0013] According to an embodiment of the present invention, the deacetylation degree of chitosan is 50%-95%, preferably, the deacetylation degree of chitosan is 70%-90%, and illustratively, it can be 70%, 75%, 80%, 85%, or 90%.

[0014] According to the embodiment of the present invention, the chitosan or its derivatives described in the present invention have antibacterial function. For example, when a 5wt% chitosan solution is used as an antibacterial component in a coagulation bath, the natural polymer antibacterial fiber has an antibacterial rate of 95% against Escherichia coli and an antibacterial rate of 96% against Staphylococcus aureus.

[0015] According to an embodiment of the present invention, the chitosan or its derivative can be water-soluble chitosan or water-soluble chitosan derivatives, such as quaternary ammonium salt chitosan; or chitosan or its derivatives that can be dissolved in the presence of an acid, wherein the acid contains, for example, one, two or more carboxyl groups.

[0016] According to an embodiment of the present invention, the method for preparing the natural polymer antibacterial fiber includes a chemical cross-linking method or a physical coating method;

[0017] In some embodiments of the present invention, the preparation method is a chemical crosslinking method. In the chemical crosslinking method, the antibacterial component coagulation bath contains a crosslinking agent. The drying temperature after the antibacterial component coagulation bath needs to be greater than the temperature of the crosslinking reaction, for example, higher than 100°C, for example, 110°C-150°C. The chemical crosslinking method is to introduce chitosan and a crosslinking agent into the antibacterial component coagulation bath containing a crosslinking agent, and then dry and crosslink to wrap the chitosan on the cellulose surface.

[0018] In some embodiments of the present invention, the preparation method is a physical coating method. In the physical coating method, the fiber passes through an antimicrobial component coagulation bath and then passes through an antisolvent system coagulation bath. The physical coating method is to introduce chitosan into the antimicrobial component coagulation bath, and then enter the antisolvent system coagulation bath to regenerate chitosan in situ so that it is wrapped on the cellulose surface.

[0019] According to an embodiment of the present invention, the commercial natural polymer fibers include cellulose fibers, silk fibers and the like.

[0020] The present invention also provides a natural high molecular antibacterial fiber prepared by the method.

[0021] According to an embodiment of the present invention, the antibacterial fiber is a skin-core structure, which comprises a natural polymer fiber core structure and a skin structure formed by an antibacterial layer from the inside to the outside.

[0022] Beneficial effects of the present invention:

[0023] (1) The present invention adopts the dissolution and regeneration of natural polymer materials to prepare gel-state natural polymer fibers, and when the fibers are in gel state, the antibacterial components are introduced through diffusion in an antibacterial component coagulation bath to prepare natural polymer antibacterial fibers with a skin-core structure. Alternatively, commercial natural polymer fibers are directly introduced with antibacterial components through an antibacterial component coagulation bath to prepare natural polymer antibacterial fibers with a skin-core structure. The present invention can achieve high-strength natural polymer antibacterial fibers: by preparing natural polymer antibacterial fibers with a skin-core structure, the core layer is a cellulose layer, which provides high strength, and the skin layer is a chitosan layer, which provides antibacterial effect. The strength of natural polymer antibacterial fibers can reach more than 400MPa, which solves the problem of low strength of chitosan fibers.

[0024] (2) The present invention can realize the continuous preparation of natural polymer antibacterial fibers: through the continuous spinning process of natural polymer fibers, antibacterial components are introduced into the surface layer of the fibers through diffusion in a coagulation bath during continuous spinning, thereby realizing the continuous production of antibacterial fibers with a skin-core structure.

[0025] (3) The present invention can achieve a high antibacterial rate when the proportion of antibacterial components is very low: chitosan is dissolved to prepare an antibacterial component coagulation bath, and chitosan is no longer soluble in water by introducing a cross-linking agent or adding an anti-solvent, so that the antibacterial component can be firmly coated on the surface of the natural polymer fiber. When the natural polymer fiber body is dried, it will shrink greatly, so that the adhesion between the antibacterial component and the natural polymer fiber of the core layer is tighter. At the same time, the concentration / content of the antibacterial component in the coagulation bath can be controlled to control the antibacterial rate of the natural polymer antibacterial fiber. Since chitosan can completely coat the cellulose surface, the layer in contact with the outside world is only the chitosan layer, so it is only necessary to have chitosan on the cellulose surface.

[0026] (4) The present invention has high economic benefits: the price of cellulose is much lower than that of chitosan, so cellulose can replace part of chitosan in the overall fiber structure, saving the cost of large-scale production.

[0027] (5) The present invention has a high environmental significance: all materials used in the present invention are 100% biodegradable materials, and no petroleum-based materials are used, which is of great significance to environmental protection.

[0028] (6) The present invention adopts natural polymer fibers and antibacterial components to prepare natural polymer antibacterial fibers. The method mainly uses excellent biomass solvent systems such as ionic liquids and sodium hydroxide-urea, and uses water, alcohol and functional components as coagulation baths. The antibacterial fibers prepared have good uniformity, good stability and controllable antibacterial rate. BRIEF DESCRIPTION OF THE DRAWINGS

[0029] Figure 1 : Scanning electron microscope photos of the antibacterial fiber prepared in Example 1 at 100 times, 2000 times and 5000 times.

[0030] Figure 2 : Scanning electron microscope photos of the antibacterial fiber prepared in Example 9 at 1000 times, 10000 times and 25000 times. DETAILED DESCRIPTION

[0031] [Preparation method of natural polymer antibacterial fiber]

[0032] As mentioned above, the present invention provides a method for preparing a natural polymer antibacterial fiber, the method comprising the following steps:

[0033] The natural polymer solution is extruded through a spinning pot nozzle and sequentially passed through a first coagulation bath and an antibacterial component coagulation bath (a second coagulation bath) to prepare the natural polymer antibacterial fiber.

[0034] According to an embodiment of the present invention, the natural polymer solution is obtained by dissolving a natural polymer material in a solvent.

[0035] According to an embodiment of the present invention, in the natural polymer solution, the concentration (solid content) of the natural polymer material is 3wt%-15wt%; specifically 6wt%-9wt%; illustratively, it can be 3wt%, 4wt%, 5wt%, 6wt%, 7wt%, 8wt%, 9wt%, 10wt%, 11wt%, 12wt%, 13wt%, 14wt% or 15wt%.

[0036] According to an embodiment of the present invention, the natural polymer material is, for example, cellulose, low-quality cellulose or natural plant tissue.

[0037] According to an embodiment of the present invention, the cellulose is selected from one or more of the following substances: microcrystalline cellulose, bacterial cellulose, cotton pulp, wood pulp, bamboo pulp, straw pulp, refined cotton, absorbent cotton, cotton linter and bagasse, wood and crop straw, etc.; preferably one or more of microcrystalline cellulose, refined cotton, absorbent cotton and wood pulp.

[0038] Preferably, the crop straw can be selected from one or more of wheat straw, rice straw, corn straw, soybean straw, cotton straw, ginger stalk, and sesame straw.

[0039] According to an embodiment of the present invention, the low-quality cellulose is a plant tissue containing at least two components, cellulose and lignin, such as herbaceous plants and / or agricultural and forestry wastes.

[0040] For example, the herbaceous plant is selected from one or more of trees, shrubs, vines, bamboos and the like.

[0041] For example, the agricultural and forestry waste is selected from one or more of bark, leaves, sawdust, crop straw, fruit shells or cores, corn cobs, bagasse, etc.

[0042] According to an embodiment of the present invention, the natural plant tissue is a plant tissue containing cellulose or lignin.

[0043] According to an embodiment of the present invention, the solvent used to dissolve the natural polymer material can be selected from one or more of the following solvents: organic solvents, ionic liquids, inorganic salts, organic salts; illustratively, selected from organic solvents, organic solvent / salt systems, carbamate systems, alkali / water systems, alkali / urea systems, alkali / thiourea systems, liquid ammonia / NH4SCN, organic acids, aqueous metal salt solutions, alcohol solutions of metal salt hydrates or water-alcohol mixed solutions of metal salt hydrates, amine oxide systems (NMMO), ionic liquids, choline-type low eutectic solvent systems, etc.

[0044] The organic solvent may be selected from one or more of N,N-dimethyl sulfoxide (DMSO), N,N-dimethylformamide (DMF), N,N-dimethylacetamide (DMAc), N-methylpyrrolidone (NMP), N-methylimidazole, imidazole, pyridine, ethylenediamine, hexafluoroacetone, hexafluoroisopropanol, glycerol, methyl isobutyl ketone, tetrahydrofuran, dioxane, and γ-valerolactone (GVL).

[0045] The organic solvent / salt system can be selected from organic solvent / metal salt, or organic solvent / organic salt, and can be selected from one or more of N,N-dimethylacetamide / lithium chloride (DMAc / LiCl) system and N,N-dimethyl sulfoxide / tetrabutylammonium fluoride system (DMSO / TBAF).

[0046] Wherein, the alkali / water system can be selected from one or both of NaOH / H2O and KOH / H2O.

[0047] Wherein, the alkali / urea system can be NaOH / Urea.

[0048] Wherein, the alkali / thiourea system can be NaOH / thio-urea.

[0049] The organic acid may be selected from one or more of formic acid, acetic acid, propionic acid, butyric acid, succinic acid, lactic acid, glutamic acid, glycine, dichloroacetic acid, trichloroacetic acid, toluenesulfonic acid, phosphoric acid and the like.

[0050] Among them, the metal salt aqueous solution can be selected from aqueous solutions of metal salts such as CaCl2, ZnCl2, LiClO4, Ca(SCN)2, LiSCN, Ca(NO)2, etc.

[0051] The alcohol solution of the metal salt hydrate may be selected from a methanol solution of CaBr2·H2O or a methanol solution of CaCl2·2H2O.

[0052] The water-alcohol mixed solution of the metal salt hydrate may be selected from a methanol aqueous solution of CaBr2·H2O or a methanol aqueous solution of CaCl2·2H2O.

[0053] Wherein, the amine oxide system can be NMMO / H2O / DMSO system, NMMO / H2O / diethyltriamine, NMMO / H2O system.

[0054] The ionic liquid can be selected from organic molten salts with a melting point below 100° C. formed by cations and anions such as imidazole, pyridine, and pyrrole, and is preferably an organic molten salt that can dissolve natural polymer materials.

[0055] For example, the cation of the ionic liquid is one or more cations selected from imidazole, pyridine, pyrrole, amine, phosphine, choline, diazabicyclic, and amino acid type cations that are unsubstituted or substituted with one, two or more substituents; for example, the substituent can be C 1-6 Alkyl, C 1-6 Alkoxy, hydroxy, -C 1-6 -OH, C 1-6 Alkenyl, phenyl, C 1-6 Alkoxy substituted phenyl or C 1-6 One or more of alkyl-substituted phenyl groups; preferably, the substituent is one or more of methyl, ethyl, propyl, butyl, allyl, benzyl, methoxymethyl, methoxyethyl, hydroxyethyl, pentyl, m-methoxybenzyl, m-methylbenzyl;

[0056] Preferably, the cation of the ionic liquid is selected from one or more of the following cations: 1-ethyl-3-methylimidazolium cation ([EMIM] + ), 3-methylimidazolium cation ([MIM] + ), 1-propyl-3-methylimidazolium cation ([PMIM] + ), 1-allyl-3-methylimidazolium cation ([AMIM] + ), 1-butyl-3-methylimidazolium cation ([BMIM] + ), 1-butyl-2,3-dimethylimidazolium cation ([BMMIM] + ), 1,3-dimethylimidazolium cation ([MMIM] + ), 1-methoxyethyl-3-methylimidazolium cation ([MeOEMIM] + ), 1-methoxymethyl-3-methylimidazolium cation ([MeOMMIM] + ), 1-hydroxy-3-methyl-imidazolium cation ([HMIM] + ), 1-(2-hydroxyethyl)-3-methylimidazolium cation ([HOEMIM] + ), 1-methyl-3-benzyl imidazolium cation ([MBzIM] + ), 1-pentyl-3-methylimidazolium cation ([PeMIM]+ ), 1-benzyl-3-methylimidazolium cation ([BzMIM] + ), 1-m-methoxybenzyl-3-methylimidazolium cation ([MeOBzMIM] + ), 1-m-methylbenzyl-3-methylimidazolium cation ([MeBzMIM] + ), N-methylpyridinium cation ([MPyr] + ), N-ethylpyridinium cation ([EPyr] + ), N-butylpyridinium cation ([BPyr] + ), N-hexylpyridinium cation ([HPyr] + ), 1-butyl-3-methylpyrrolidinium ion ([BMPyrr] + ), tris(2-hydroxyethyl)methylamine ([THEMA] + ), tetrabutylamine ([TBA] + ), tetrabutylphosphine ([PBu4] + ), glycine cation ([Gly] + ), choline cation ([Ch] + ), 1,5-diazabicyclo[4.3.0]keto-5-ene ([DBNH] + )wait.

[0057] More preferably, the cation of the ionic liquid is selected from one or more of the following cations: 1-ethyl-3-methylimidazolium cation ([EMIM] + ), 1-allyl-3-methylimidazolium cation ([AMIM] + ), 1-butyl-3-methylimidazolium cation ([BMIM] + ), choline cation ([Ch] + )wait.

[0058] For example, the anion of the ionic liquid is selected from one or more of halogen anions, organic acid radical ions, organic acid ester anions, amino acid type anions, and the like.

[0059] Preferably, the anion of the ionic liquid is selected from one or more of the following anions: chloride ion ([Cl] - ), bromide ion ([Br] - ), fluoride ion ([F] - ), formate ion ([HCOO] - ), acetate ion ([CH3COO] - or [Ac] - ), hydroxyacetate ion ([HOCH2COO] - ), propionate ion ([CH3CH2COO]- or [OPr] - ), butyrate ion ([CH3CH2CH2COO] - or [OBu] - ), octanoate ([Oct] - ), benzoate ion ([C6H5COO] - or [PhCOO] - ), lactate ion ([CH3CH(OH)COO] - or [Lac] - ), thioglycolate ion ([HSCH2COO] - ), hexafluorophosphate ion ([PF6] - ), trifluoroborate ([BF3] - ), methyl phosphate ion ([(MeO)HPO2] - or [MP] - ), dimethyl phosphate ion ([(MeO)2PO2] - or [DMP] - ), diethyl phosphate ion ([(EtO)2PO2] - or [DEP] - ), methanesulfonate anion ([MeOSO3] - ), trifluoromethanesulfonate anion ([CF3SO3] - ), glycine anion ([Gly] - ), lysine anion ([Lys] - ), valine anion ([Val] - ), dicyanamide anion ([N(CN)2] - or [DCA] - ), bis(trifluoromethanesulfonimide) ([Tf2N] - )wait.

[0060] More preferably, the anion of the ionic liquid is selected from one or more of the following anions: chloride ion ([Cl] - ), formate ion ([HCOO] - ), acetate ion ([Ac] - ), methyl phosphate ion ([(MeO)HPO2] - or [MP] - ), dimethyl phosphate ion ([(MeO)2PO2] - or [DMP] - ), and dicyanamide anion ([N(CN)2] - or [DCA] - )wait.

[0061] According to the present invention, the ionic liquid can be selected from 1-ethyl-3-methylimidazolium chloride ionic liquid ([EMIM][Cl]), 1-ethyl-3-methylimidazolium bromide ionic liquid ([EMIM][Br]), 1-ethyl-3-methylimidazolium formate ionic liquid ([EMIM][HCOO]), 1-ethyl-3-methylimidazolium acetate ionic liquid ([EMIM][Ac]), 1-ethyl-3-methylimidazolium octanoate ionic liquid ([EMIM][Oct]), 1-ethyl-3-methylimidazolium methyl phosphate ionic liquid ([EMIM][MP]), 1-ethyl-3-methylimidazolium dimethyl phosphate ionic liquid ([EMIM][DMP]), 1-ethyl-3 1-ethyl-3-methylimidazolium diethyl phosphate ionic liquid ([EMIM][DEP]), 1-ethyl-3-methylimidazolium propionate ionic liquid ([EMIM][OPr]), 1-ethyl-3-methylimidazolium top ionic liquid ([EMIM][OBu]), 1-ethyl-3-methylimidazolium glycinate ionic liquid ([EMIM][Gly]), 1-ethyl-3-methylimidazolium lysine ionic liquid ([EMIM][Lys]), 1-allyl-3-methylimidazolium chloride ionic liquid ([AMIM][Cl]), 1-allyl-3-methylimidazolium bromide ionic liquid ([AMIM][Br]), 1-allyl-3-methylimidazolium formate ionic liquid ([AMIM][ HCOO]), 1-allyl-3-methylimidazolium acetate ionic liquid ([AMIM][Ac]), 1-butyl-3-methylimidazolium chloride ionic liquid ([BMIM][Cl]), 1-butyl-3-methylimidazolium bromide ionic liquid ([BMIM][Br]), 1-butyl-3-methylimidazolium formate ionic liquid ([BMIM][HCOO]), 1-butyl-3-methylimidazolium acetate ionic liquid ([BMIM][Ac]), 1-butyl-3-methylimidazolium hydroxyacetate ionic liquid ([BMIM][HOCH2COO]), 1-butyl-3-methylimidazolium propionate ionic liquid ([BMIM][CH3CH2COO]), 1-butyl-3-methyl imidazolium lactate ionic liquid [BMIM][Lac], 1-butyl-3-methylimidazolium butyrate ionic liquid ([BMIM][CH3CH2CH2COO]), 1-butyl-3-methylimidazolium benzoate ionic liquid ([BMIM][C6H5COO]), 1-butyl-3-methylimidazolium glycinate ionic liquid ([BMIM][H2NCH2COO]), 1-butyl-3-methylimidazolium dicyanamide ionic liquid ([BMIM][N(CN)2]), 1-butyl-3-methylimidazolium bistrifluoromethylsulfonyl imide ionic liquid ([BMIM][Tf2N]), 1-butyl-3-methylimidazolium hexafluorophosphate ionic liquid ([BMIM][PF6]),1-Butyl-3-methylimidazolium tetrafluoroborate ionic liquid ([BMIM][BF4]), 1-Butyl-3-methylimidazolium methylsulfonate ionic liquid ([BMIM][MeOSO3]), 1-Butyl-3-methylimidazolium trifluoromethylsulfonate ionic liquid ([BMIM][CF3SO3]), 1-Butyl-2,3-dimethylimidazolium tetrafluoroborate ionic liquid ([BMMIM][BF4]), 3-methylimidazolium formate ionic liquid ([MIM][HCOO]), 1,3-dimethylimidazolium chloride ionic liquid ([MMIM][Cl]), 1,3-dimethylimidazolium methyl phosphate ionic liquid ([MMIM][MP]), 1,3-dimethyl Ionic liquids include 1-(2-hydroxyethyl)-3-methylimidazolium chloride ([HOEMIM][Cl]), 1-(2-hydroxyethyl)-3-methylimidazolium bromide ([MeOMMIM][Br]), 1-(2-hydroxyethyl)-3-methylimidazolium bromide ([MeOMMIM][Br]), 1-(2-methoxyethyl)-3-methylimidazolium bromide ([MeOEMIM][Br]), 1-(2-hydroxyethyl)-3-methylimidazolium chloride ([HOEMIM][Cl]), 1-(2-methoxy ... bromide ([HOEMIM][Cl]), 1-(2-hydroxyethyl)-3-methylimidazolium bromide ([HOEMIM][Cl]), 1-(2-hydroxyethyl)-3-methylimidazolium bromide ([HOEMIM][Cl]), 1-(2-hydroxyethyl)-3-methylimidazolium bromide ( -Ethylpyridinium chloride ionic liquid ([EPyr][Cl]), N-ethylpyridinium bromide ionic liquid ([EPyr][Br]), N-methylpicolinate ionic liquid ([MPyr][HCOO]), tris(2-hydroxyethyl)methylamine acetate ionic liquid ([THEMA][Ac]), tris(2-hydroxyethyl)methylamine methylsulfonate ionic liquid ([THEMA][MeOSO3]), tris(2-hydroxyethyl)methylamine trifluoromethylsulfonate ionic liquid [THEMA][CF3SO3], tetrabutylphosphine valine ionic liquid [PBu4][Val], tetrabutylphosphine lysine ionic liquid [PBu4][Lys], tetrabutylphosphine glycin ...Ac], tris(2-hydroxyethyl)methylamine methylsulfonate ionic liquid [THEMA][MeOSO3], tris(2-hydroxyethyl)methylamine trifluoromethylsulfonate ionic liquid [THEMA][CF3SO3], tetrabutylphosphine valine ionic liquid [PBu4][Val], tetrabutylphosphine lysine ionic liquid [PBu4][Lys], tetrabutylphosphine Subliquid [PBu4][Gly], 1-benzyl-3-methylimidazolium chloride ionic liquid ([BzMIM][Cl]), 1-benzyl-3-methylimidazolium dicyanamide ionic liquid ([BzMIM][DCA]), 1-m-methylbenzyl-3-methylimidazolium chloride ionic liquid ([MeBzMIM][Cl]), 1-m-methoxybenzyl-3-methylimidazolium chloride ionic liquid ([MeOBzMIM][Cl]), choline chloride ionic liquid ([Ch][Cl]), choline bromide ionic liquid ([Ch][Br]), choline acetate ionic liquid ([Ch][CH3COO]), choline propionate ionic liquid ([Ch][CH3CH2COO]),One or more of ionic liquids such as choline butyrate ionic liquid ([Ch][CH3CH2CH2COO]), glycine hydrochloride ionic liquid ([Gly][Cl]), 1,5-diazabicyclo[4.3.0]keto-5-ene acetate ionic liquid ([DBNH][Ac]).

[0062] According to the present invention, the ionic liquid can be a single ionic liquid or a mixture of multiple ionic liquids; for example, the single ionic liquid is an ionic liquid that can completely dissolve or partially dissolve the natural polymer material; for example, the ionic liquid mixture can be all ionic liquids that can dissolve the natural polymer material, or it can be a mixture of ionic liquids that can dissolve the natural polymer material and ionic liquids that cannot dissolve the natural polymer material.

[0063] The choline-based deep eutectic solvent system may be selected from one or more of [Ch][Cl] / urea, [Ch][Br] / urea, [Ch][Cl] / thio-urea, [Ch][Cl] / glycerol, and [Ch][Cl] / lactic acid.

[0064] Illustratively, the cellulose dissolving solvent has the above meaning; more preferably, the cellulose dissolving solvent is selected from one or more of [AMIM][Cl], [BMIM][Cl], [EMIM][Ac], [BMIM][Ac].

[0065] According to an embodiment of the present invention, the first coagulation bath is water, alcohol or a mixed solution of water and alcohol.

[0066] According to an embodiment of the present invention, the alcohol is, for example, selected from methanol, ethanol, propanol, n-butanol, glycerol, ethylene glycol, isopropanol or isobutanol.

[0067] According to an embodiment of the present invention, the antibacterial component coagulation bath is a chitosan solution or a chitosan derivative solution. The concentration (solid content) of the solution is, for example, 1wt%-20wt%, or 3wt%-10wt%, specifically 2wt%, 3wt%, 4wt%, 5wt%, 6wt%, 7wt%, 8wt%, 9wt%, 10wt%, 11wt%, 12wt%, 13wt%, 14wt% or 15wt%.

[0068] According to an embodiment of the present invention, the deacetylation degree of the chitosan is 50%-95%, preferably, the deacetylation degree of the chitosan is 70%-90%.

[0069] According to an embodiment of the present invention, the chitosan or its derivatives may be water-soluble chitosan or water-soluble chitosan derivatives, such as quaternary ammonium chitosan; or chitosan or its derivatives that can be dissolved in the presence of an acid. The acid may contain, for example, one, two or more carboxyl groups, and may specifically be formic acid, acetic acid, propionic acid, butyric acid, valeric acid, caproic acid, capric acid, oxalic acid, malonic acid, succinic acid, glutaric acid, adipic acid, capric acid, etc.

[0070] According to an embodiment of the present invention, the chitosan derivative of the present invention refers to a product generated by a chemical reaction such as alkylation, acylation, carboxymethylation, sulfonation, nitration, halogenation, oxidation, reduction, condensation, etc. of chitosan, but the amino groups thereof need to be retained from further reaction. The chitosan derivative may specifically be: quaternary ammonium salt chitosan.

[0071] According to an embodiment of the present invention, the antimicrobial component coagulation bath comprises an antimicrobial component (e.g., chitosan or a chitosan derivative) and a solvent. Specifically, the solvent is, for example, water, or a mixture of water and one or more acids. The acid, for example, contains one, two or more carboxyl groups, and specifically can be a monobasic acid, a dibasic acid, or a tribasic acid; for example, an alkyl acid (e.g., formic acid, acetic acid, propionic acid, butyric acid, valeric acid, caproic acid, and caprylic acid), an alkyl diacid (e.g., oxalic acid, malonic acid, succinic acid, glutaric acid, adipic acid, and caprylic acid), etc.

[0072] In some embodiments of the present invention, the preparation method is a chemical crosslinking method. In the chemical crosslinking method, the antibacterial component coagulation bath contains a crosslinking agent. The crosslinking agent is, for example, a dibasic acid or a tribasic acid, specifically an alkyl diacid, such as oxalic acid, malonic acid, succinic acid, glutaric acid, adipic acid, sebacic acid, and the like. In some embodiments, the crosslinking agent is the same as the acid that dissolves chitosan. In some embodiments of the present invention, the antibacterial component coagulation bath containing a crosslinking agent is prepared by the following method: dissolving chitosan or its derivatives and a crosslinking agent in water, filtering impurities, evaporating and concentrating, then adding alcohol (such as methanol) to precipitate chitosan or its derivatives, drying, and then dissolving the resulting solid in water. The drying is, for example, placed in a vacuum oven for drying, such as drying at 60-100°C for 5-24 hours.

[0073] In some embodiments of the present invention, the antimicrobial component coagulation bath containing a crosslinker is prepared by dissolving chitosan or a derivative thereof in water, optionally adding an acid (such as a monobasic acid), and then adding a crosslinker (such as a dibasic acid).

[0074] In some embodiments of the present invention, in the chemical crosslinking method, the fiber passes through the antibacterial component coagulation bath, and then is dried and crosslinked at high temperature. The temperature needs to be higher than the temperature of the crosslinking reaction, such as higher than 100°C, such as 110°C-150°C.

[0075] In some embodiments of the present invention, the preparation method is a physical coating method. In the physical coating method, the fiber is subjected to an antimicrobial component coagulation bath and then to an anti-solvent system coagulation bath (third coagulation bath).

[0076] According to an embodiment of the present invention, the antimicrobial component coagulation bath is defined as above. In some embodiments, the antimicrobial component coagulation bath contains chitosan and its derivatives, water, and optionally one or more acids, wherein the acid may be, for example, a monobasic acid, a dibasic acid, or a tribasic acid; specifically, an alkyl acid (such as formic acid, acetic acid, propionic acid, butyric acid, valeric acid, caproic acid, and capric acid), an alkyl diacid (such as oxalic acid, malonic acid, succinic acid, glutaric acid, adipic acid, and capric acid), and the like.

[0077] According to an embodiment of the present invention, the anti-solvent system coagulation bath is an aqueous solution of alkali, such as an aqueous solution of sodium hydroxide, an aqueous solution of potassium hydroxide, etc. The concentration of the solution is, for example, 1-10 mol / L.

[0078] In some embodiments of the present invention, the physical coating method comprises: extruding the natural polymer solution through a spinning pot nozzle, and sequentially passing through a first coagulation bath, an antibacterial component coagulation bath, and an anti-solvent system coagulation bath, and drying to obtain the natural polymer antibacterial fiber. The drying temperature is preferably below 100°C, for example 60-100°C.

[0079] Exemplarily, the method for preparing the natural polymer antibacterial fiber includes:

[0080] The natural polymer solution is degassed and poured into a spinning pot, and squeezed out from the nozzle of the spinning pot by pressure; then it passes through a drawing roller and enters a first coagulation bath (i.e., water or alcohol solution) to prepare a core layer; then it enters an antibacterial component coagulation bath; and then it is dried by a hot roller to obtain the natural polymer antibacterial fiber.

[0081] In the present invention, there is no particular limitation on the magnitude of the pressure, as long as the natural polymer solution can be squeezed out from the nozzle.

[0082] [Natural polymer antibacterial fiber]

[0083] As mentioned above, the present invention provides a natural high molecular weight antibacterial fiber prepared by the above method.

[0084] According to an embodiment of the present invention, the antibacterial fiber is a skin-core structure, which comprises a natural polymer fiber core structure and a skin structure formed by an antibacterial layer from the inside to the outside.

[0085] According to an embodiment of the present invention, the cross-section of the natural high molecular weight antibacterial fiber is circular and has a skin-core structure.

[0086] According to an embodiment of the present invention, the antibacterial component in the antibacterial layer is selected from chitosan or chitosan derivatives. The thickness of the antibacterial layer is, for example, 1-20 μm.

[0087] In some embodiments of the present invention, the core layer of the antibacterial fiber is a dissolved regenerated fiber of a natural polymer material, which is used to provide strength, and the antibacterial layer is used to provide antibacterial properties.

[0088] According to an embodiment of the present invention, the natural polymer material dissolved regenerated fiber can be a bundle of fibers or a single fiber; specifically, the size (diameter) of the natural polymer material dissolved regenerated fiber ranges from 5 μm to 500 μm, which can be detected by optical microscopy and cryo-scanning electron microscopy data, and the preferred size (diameter) is 10 μm to 50 μm.

[0089] [application]

[0090] The present invention also provides the application of the above natural polymer antibacterial fiber in antibacterial textiles, such as clothing, household textiles, industrial textiles, medical supplies, such as surgical sutures, antibacterial clothing, etc.

[0091] The technical scheme of the present invention will be further described in detail below in conjunction with specific embodiments. It should be understood that the following embodiments are only exemplary descriptions and explanations of the present invention and should not be construed as limiting the scope of protection of the present invention. All technologies implemented based on the above content of the present invention are included in the scope that the present invention is intended to protect.

[0092] Unless otherwise specified, the raw materials and reagents used in the following examples are commercially available or can be prepared by known methods.

[0093] [Preparation of chitosan solution]

[0094] Preparation Example 1

[0095] 9g chitosan and 6g succinic acid were dissolved in 285g water. After complete dissolution, impurities were filtered out and then evaporated and concentrated. Chitosan was precipitated with sufficient methanol and then dried in a vacuum oven at 60°C for 12h. Chitosan solutions of different concentrations were then dissolved in water.

[0096] Preparation Example 2

[0097] 15 g of chitosan and 6 g of acetic acid were dissolved in 279 g of water. After they were completely dissolved, 1 g of succinic acid was added to obtain a chitosan solution.

[0098] [Chitosan with different deacetylation degrees]

[0099] Example 1

[0100] 6 g of wood pulp with a degree of polymerization of 549 after drying is added to a three-necked flask, and 94 g of 1-allyl-3-methylimidazolium chloride ionic liquid ([AMIM][Cl]) is added. After stirring at 80°C for 2 hours, a cellulose solution is formed. The cellulose solution is degassed and poured into a spinning tank. The solution is squeezed out from the spinning tank nozzle by pressure, and then passes through a drawing roller into a water coagulation bath, and then enters a 5wt% chitosan solution with a degree of deacetylation of 75% prepared according to the method of Preparation Example 1, and then is dried by a hot roller at a temperature of 130°C to obtain the natural polymer antibacterial fiber.

[0101] The antibacterial properties of the natural polymer antibacterial fiber of the present invention were tested using Escherichia coli and Staphylococcus aureus. S.aureus =0.6,OD E.coli =1) and 50 mg of antibacterial fiber were cultured in the dark for 30 minutes. Serial dilutions were performed using PBS solution until a highly diluted bacterial solution (2×10 -5 times). Take 100 μL of the diluted bacterial solution, spread it on a semi-solid agar culture dish, and incubate it at 37°C for 16 hours to form colonies. The antibacterial performance is characterized by the antibacterial rate of colony forming units (CFU) in the experimental group (adding antibacterial substances and PBS) and the control group (adding only PBS). The antibacterial rate (%) is calculated by the following formula:

[0102] Antibacterial rate (%) = (CFU 对比 -CFU 样品 ) / CFU 对比 ×100%

[0103] The natural high molecular weight antibacterial fiber prepared in Example 1 has an antibacterial rate of 93.1% against Escherichia coli and 93.2% against Staphylococcus aureus.

[0104] The tensile strength of the natural polymer antibacterial fiber prepared in Example 1 is 465 MPa.

[0105] The scanning electron microscope photos of the natural polymer antibacterial fiber prepared in Example 1 at different magnifications are as follows Figure 1 shown.

[0106] Example 2

[0107] 6g of wood pulp with a degree of polymerization of 549 after drying was added to a three-necked flask, and 94g of 1-allyl-3-methylimidazolium chloride ionic liquid ([AMIM][Cl]) was added. After stirring at 80°C for 2h, a cellulose solution was formed. The cellulose solution was degassed and poured into a spinning pot. The solution was squeezed out from the spinning pot nozzle by pressure, and then passed through a drafting roller to enter a water coagulation bath, and then entered a 5wt% chitosan solution with a deacetylation degree of 80% prepared according to the method of Preparation Example 1, and then dried by a hot roller at a temperature of 130°C to obtain the natural polymer antibacterial fiber. The antibacterial rate against Escherichia coli was 93.6%, and the antibacterial rate against Staphylococcus aureus was 94.1%.

[0108] Example 3

[0109] 6g of wood pulp with a degree of polymerization of 549 after drying was added to a three-necked flask, and 94g of 1-allyl-3-methylimidazolium chloride ionic liquid ([AMIM][Cl]) was added. After stirring at 80°C for 2h, a cellulose solution was formed. The cellulose solution was degassed and poured into a spinning pot. The solution was squeezed out from the spinning pot nozzle by pressure, and then passed through a drafting roller to enter a water coagulation bath, and then entered a 5wt% chitosan solution with a deacetylation degree of 85% prepared according to the method of Preparation Example 1, and then dried by a hot roller at a temperature of 130°C to obtain the natural polymer antibacterial fiber. The antibacterial rate against Escherichia coli was 94.2%, and the antibacterial rate against Staphylococcus aureus was 94.5%.

[0110] Example 4

[0111] 6g of wood pulp with a degree of polymerization of 549 after drying was added to a three-necked flask, and 94g of 1-allyl-3-methylimidazolium chloride ionic liquid ([AMIM][Cl]) was added. After stirring at 80°C for 2h, a cellulose solution was formed. The cellulose solution was degassed and poured into a spinning pot. The solution was squeezed out from the spinning pot nozzle by pressure, and then passed through a drafting roller to enter a water coagulation bath, and then entered a 5wt% chitosan solution with a deacetylation degree of 90% prepared according to the method of Preparation Example 1, and then dried by a hot roller at a temperature of 130°C to obtain the natural polymer antibacterial fiber. The antibacterial rate against Escherichia coli was 95.1%, and the antibacterial rate against Staphylococcus aureus was 96.0%.

[0112] [Different coagulation bath concentrations]

[0113] Example 5

[0114] 6g of wood pulp with a degree of polymerization of 549 after drying was added to a three-necked flask, and 94g of 1-allyl-3-methylimidazolium chloride ionic liquid ([AMIM][Cl]) was added. After stirring at 80°C for 2h, a cellulose solution was formed. The cellulose solution was degassed and poured into a spinning pot. The solution was squeezed out from the nozzle of the spinning pot by pressure, and then passed through a drafting roller to enter a water coagulation bath, and then entered a 3wt% chitosan solution with a deacetylation degree of 75% prepared according to the method of Preparation Example 1, and then dried by a hot roller at a temperature of 130°C to obtain the natural polymer antibacterial fiber. The antibacterial rate against Escherichia coli was 89.1%, and the antibacterial rate against Staphylococcus aureus was 90.4%.

[0115] Example 6

[0116] 6g of wood pulp with a degree of polymerization of 549 after drying was added to a three-necked flask, and 94g of 1-allyl-3-methylimidazolium chloride ionic liquid ([AMIM][Cl]) was added. After stirring at 80°C for 2h, a cellulose solution was formed. The cellulose solution was degassed and poured into a spinning pot. The solution was squeezed out from the spinning pot nozzle by pressure, and then passed through a drafting roller to enter a water coagulation bath, and then entered a 7wt% chitosan solution with a deacetylation degree of 75% prepared according to the method of Preparation Example 1, and then dried by a hot roller at a temperature of 130°C to obtain the natural polymer antibacterial fiber. The antibacterial rate against Escherichia coli was 94.5%, and the antibacterial rate against Staphylococcus aureus was 95.3%.

[0117] Example 7

[0118] 6g of wood pulp with a degree of polymerization of 549 after drying was added to a three-necked flask, and 94g of 1-allyl-3-methylimidazolium chloride ionic liquid ([AMIM][Cl]) was added. After stirring at 80°C for 2h, a cellulose solution was formed. The cellulose solution was degassed and poured into a spinning pot. The solution was squeezed out from the spinning pot nozzle by pressure, and then passed through a drafting roller to enter a water coagulation bath, and then entered a 10wt% chitosan solution with a deacetylation degree of 75% prepared according to the method of Preparation Example 1, and then dried by a hot roller at a temperature of 130°C to obtain the natural polymer antibacterial fiber. The antibacterial rate against Escherichia coli was 95.3%, and the antibacterial rate against Staphylococcus aureus was 96.2%.

[0119] Example 8

[0120] 6g of wood pulp with a degree of polymerization of 549 after drying was added to a three-necked flask, and 94g of 1-allyl-3-methylimidazolium chloride ionic liquid ([AMIM][Cl]) was added. After stirring at 80°C for 2h, a cellulose solution was formed. The cellulose solution was degassed and poured into a spinning pot. The solution was squeezed out from the spinning pot nozzle by pressure, and then passed through a drafting roller to enter a water coagulation bath, and then entered a 5wt% chitosan aqueous solution with a deacetylation degree of 75% prepared according to the method of Preparation Example 2, and then dried by a hot roller at a temperature of 130°C to obtain the natural polymer antibacterial fiber. The antibacterial rate against Escherichia coli was 93.0%, and the antibacterial rate against Staphylococcus aureus was 90.2%.

[0121] The tensile strength of the natural polymer antibacterial fiber prepared in Example 8 is 485.7 MPa.

[0122] Example 9

[0123] 6g of wood pulp with a degree of polymerization of 549 after drying is added to a three-necked flask, and 94g of 1-allyl-3-methylimidazolium chloride ionic liquid ([AMIM][Cl]) is added. After stirring at 80°C for 2h, a cellulose solution is formed. The cellulose solution is degassed and poured into a spinning pot. The solution is squeezed out from the spinning pot nozzle by pressure, and then first passes through a drafting roller into a water coagulation bath, and then enters a 5wt% chitosan solution with a deacetylation degree of 75% (the solution is obtained by dissolving chitosan with a deacetylation degree of 75% in an acetic acid aqueous solution), and then enters a 2.5mol / L sodium hydroxide aqueous solution, and then is dried by a hot roller at a temperature of 70°C to obtain the natural polymer antibacterial fiber. The antibacterial rate against Escherichia coli is 93.5%, and the antibacterial rate against Staphylococcus aureus is 97.0%.

[0124] The tensile strength of the natural polymer antibacterial fiber prepared in Example 9 is 523.7 MPa.

[0125] The scanning electron microscope photos of the natural polymer antibacterial fiber prepared in Example 9 at different magnifications are as follows Figure 2 shown.

[0126] Example 10

[0127] 6g of wood pulp with a degree of polymerization of 549 after drying was added to a three-necked flask, and 94g of 1-allyl-3-methylimidazolium chloride ionic liquid ([AMIM][Cl]) was added. After stirring at 80°C for 2h, a cellulose solution was formed. The cellulose solution was degassed and poured into a spinning pot. The solution was squeezed out from the spinning pot nozzle by pressure, and then passed through a drafting roller to enter a water coagulation bath, and then entered a 5wt% quaternary ammonium salt chitosan aqueous solution (the aqueous solution was prepared in a similar manner to Preparation Example 1), and then dried by a hot roller at a temperature of 130°C to obtain the natural polymer antibacterial fiber. The antibacterial rate against Escherichia coli was 86.2%, and the antibacterial rate against Staphylococcus aureus was 83.2%.

Claims

1. A method for preparing a natural polymer antibacterial fiber, the method comprising the following steps: extruding a natural polymer solution through a spinning tank nozzle, and sequentially passing through a first coagulation bath and an antibacterial component coagulation bath, and drying to obtain the natural polymer antibacterial fiber; or directly passing a commercial natural polymer fiber through an antibacterial component coagulation bath, and drying to obtain the natural polymer antibacterial fiber.

2. The preparation method according to claim 1, wherein The concentration (solid content) of the natural polymer solution is 3wt%-15wt%, specifically 6wt%-9wt%.

3. The preparation method according to claim 1, wherein The natural polymer solution is obtained by dissolving a natural polymer material in a solvent, wherein the natural polymer material is cellulose, low-quality cellulose or natural plant tissue; Preferably, the cellulose is selected from one or more of the following substances: microcrystalline cellulose, bacterial cellulose, cotton pulp, wood pulp, bamboo pulp, straw pulp, refined cotton, absorbent cotton, cotton linters, bagasse, wood and crop straw, etc.; Preferably, the low-quality cellulose is a plant tissue containing at least two components, cellulose and lignin, such as herbaceous plants and / or agricultural and forestry wastes; Preferably, the natural plant tissue is a plant tissue containing cellulose or lignin. Preferably, the solvent is selected from one or more of the following solvents: organic solvents, ionic liquids, inorganic salts, organic salts; illustratively, selected from organic solvents, organic solvent / salt systems, carbamate systems, alkali / water systems, alkali / urea systems, alkali / thiourea systems, liquid ammonia / NH4SCN, organic acids, aqueous metal salt solutions, alcohol solutions of metal salt hydrates or water-alcohol mixed solutions of metal salt hydrates, amine oxide systems (NMMO), ionic liquids, choline-type low eutectic solvent systems, etc.

4. The preparation method according to claim 1, wherein The first coagulation bath is water, alcohol, or a mixed solution of water and alcohol. Preferably, the alcohol solution is selected from methanol, ethanol, propanol, n-butanol, glycerol, ethylene glycol, isopropanol or isobutanol.

5. The preparation method according to claim 1, wherein The antibacterial component coagulation bath is a solution of chitosan or a derivative thereof, and the concentration (solid content) of the solution is, for example, 1 wt%-20 wt%, or 3 wt%-10 wt%. Preferably, the deacetylation degree of the chitosan is 50%-95%, and preferably, the deacetylation degree of the chitosan is 70%-90%.

6. The preparation method according to claim 1, wherein The antibacterial component coagulation bath includes an antibacterial component (e.g., chitosan or a chitosan derivative) and a solvent. Specifically, the solvent is, for example, water, or a mixture of water and one or more acids. The acid is, for example, a monobasic acid, a dibasic acid, or a tribasic acid; for example, an alkyl acid (e.g., formic acid, acetic acid, propionic acid, butyric acid, valeric acid, caproic acid, and capric acid), an alkyl diacid (e.g., oxalic acid, malonic acid, succinic acid, glutaric acid, adipic acid, and capric acid), and the like.

7. The preparation method according to any one of claims 1 to 6, wherein: The antibacterial component coagulation bath contains a cross-linking agent; the drying temperature after the antibacterial component passes through the coagulation bath is higher than 100°C, for example, 110°C-150°C. Preferably, the cross-linking agent is, for example, a dibasic acid or a tribasic acid, specifically, an alkyl diacid, such as oxalic acid, malonic acid, succinic acid, glutaric acid, adipic acid, sebacic acid, etc.; Preferably, the cross-linking agent is the same as the acid that dissolves the chitosan.

8. The preparation method according to claim 7, wherein: The antimicrobial component coagulation bath containing a crosslinking agent is prepared by the following method: Dissolve chitosan or its derivative and a cross-linking agent in water, filter impurities, evaporate and concentrate, then add alcohol (such as methanol) to precipitate chitosan or its derivative, dry, and then dissolve the resulting solid in water. The drying may be, for example, drying in a vacuum oven, such as drying at 60-100° C. for 5-24 hours; Alternatively, chitosan or its derivatives are dissolved in water, and an acid (such as a monobasic acid) is optionally added, followed by a cross-linking agent (such as a dibasic acid).

9. The preparation method according to any one of claims 1 to 6, wherein: The fiber is subjected to an antimicrobial component coagulation bath, then to an anti-solvent system coagulation bath, and then to drying; Preferably, the anti-solvent system coagulation bath is an aqueous solution of alkali, such as an aqueous solution of sodium hydroxide, an aqueous solution of potassium hydroxide, etc. The concentration of the solution is, for example, 1-10 mol / L.

10. The natural high molecular weight antibacterial fiber prepared by the method according to any one of claims 1 to 9; Preferably, the antibacterial fiber is a skin-core structure, which comprises, from the inside to the outside, a natural polymer fiber core structure and a skin structure formed by an antibacterial layer.